首页> 外文期刊>Scientific reports. >Electrospun SF/PLCL nanofibrous membrane: a potential scaffold for retinal progenitor cell proliferation and differentiation
【24h】

Electrospun SF/PLCL nanofibrous membrane: a potential scaffold for retinal progenitor cell proliferation and differentiation

机译:电纺SF / PLCL纳米纤维膜:潜在的视网膜祖细胞增殖和分化的支架。

获取原文
           

摘要

Biocompatible polymer scaffolds are promising as potential carriers for the delivery of retinal progenitor cells (RPCs) in cell replacement therapy for the repair of damaged or diseased retinas. The primary goal of the present study was to investigate the effects of blended electrospun nanofibrous membranes of silk fibroin (SF) and poly(L-lactic acid-co-ε-caprolactone) (PLCL), a novel scaffold, on the biological behaviour of RPCs in vitro . To assess the cell-scaffold interaction, RPCs were cultured on SF/PLCL scaffolds for indicated durations. Our data revealed that all the SF/PLCL scaffolds were thoroughly cytocompatible, and the SF:PLCL (1:1) scaffolds yielded the best RPC growth. The in vitro proliferation assays showed that RPCs proliferated more quickly on the SF:PLCL (1:1) than on the other scaffolds and the control. Quantitative polymerase chain reaction (qPCR) and immunocytochemistry analyses demonstrated that RPCs grown on the SF:PLCL (1:1) scaffolds preferentially differentiated toward retinal neurons, including, most interestingly, photoreceptors. In summary, we demonstrated that the SF:PLCL (1:1) scaffolds can not only markedly promote RPC proliferation with cytocompatibility for RPC growth but also robustly enhance RPCs’ differentiation toward specific retinal neurons of interest in vitro , suggesting that SF:PLCL (1:1) scaffolds may have potential applications in retinal cell replacement therapy in the future.
机译:生物相容性聚合物支架有望在细胞替代疗法中用于修复受损或患病的视网膜的视网膜祖细胞(RPC)的潜在载体。本研究的主要目的是研究丝素蛋白(SF)和新型支架L(乳酸-co-ε-己内酯)(PLCL)的混合电纺纳米纤维膜对小鼠的生物学行为的影响。体外RPCs。为了评估细胞-支架相互作用,将RPC在SF / PLCL支架上培养指定的持续时间。我们的数据显示,所有SF / PLCL支架都具有完全的细胞相容性,并且SF:PLCL(1:1)支架产生了最佳的RPC生长。体外增殖试验表明,与其他支架和对照组相比,SF:PLCL(1:1)上的RPC增殖更快。定量聚合酶链反应(qPCR)和免疫细胞化学分析表明,在SF:PLCL(1:1)支架上生长的RPC优先向视网膜神经元分化,包括最有趣的是感光细胞。总而言之,我们证明了SF:PLCL(1:1)支架不仅可以显着促进RPC增殖,并具有与RPC生长相关的细胞相容性,而且还可以在体外强烈增强RPCs向感兴趣的特定视网膜神经元的分化,这表明SF:PLCL( 1:1)支架将来可能在视网膜细胞替代治疗中有潜在的应用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号